{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:27:42Z","timestamp":1789720062884,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2502700"],"award-info":[{"award-number":["2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82020108003\u300182330008"],"award-info":[{"award-number":["82020108003\u300182330008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"crossref","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Medical Innovation Center","award":["CXZX202201"],"award-info":[{"award-number":["CXZX202201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06957-7","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:12:15Z","timestamp":1774253535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions"],"prefix":"10.1007","volume":"105","author":[{"given":"Shuangzhu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongsheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-sen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"6957_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"YF Liu","year":"2016","unstructured":"Liu YF et al (2016) Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. EBioMedicine 8:173\u2013183","journal-title":"EBioMedicine"},{"key":"6957_CR2","doi-asserted-by":"publisher","first-page":"13331","DOI":"10.1038\/ncomms13331","volume":"7","author":"Z Gu","year":"2016","unstructured":"Gu Z et al (2016) Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun 7:13331","journal-title":"Nat Commun"},{"issue":"28","key":"6957_CR3","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1200\/JCO.2016.66.5547","volume":"34","author":"K Suzuki","year":"2016","unstructured":"Suzuki K et al (2016) MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. J Clin Oncol 34(28):3451\u20133459","journal-title":"J Clin Oncol"},{"issue":"5","key":"6957_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ng.3535","volume":"48","author":"T Yasuda","year":"2016","unstructured":"Yasuda T et al (2016) Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet 48(5):569\u2013574","journal-title":"Nat Genet"},{"key":"6957_CR5","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebjorn","year":"2016","unstructured":"Lilljebjorn H et al (2016) Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun 7:11790","journal-title":"Nat Commun"},{"issue":"10","key":"6957_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TS Heng","year":"2008","unstructured":"Heng TS, Painter MW (2008) Immunological Genome Project, The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 9(10):1091\u20131094","journal-title":"Nat Immunol"},{"issue":"5","key":"6957_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood-2015-04-643270","volume":"127","author":"J Herglotz","year":"2016","unstructured":"Herglotz J et al (2016) Essential control of early B-cell development by Mef2 transcription factors. Blood 127(5):572\u2013581","journal-title":"Blood"},{"key":"6957_CR8","doi-asserted-by":"crossref","unstructured":"Chevalier S, Legrand C (2024) B-cell acute lymphoblastic leukemia with MEF2D::BCL9 rearrangement mimicking a Burkitt lymphoma. Blood, 144(19): p. 2067","DOI":"10.1182\/blood.2024026200"},{"key":"6957_CR9","doi-asserted-by":"crossref","unstructured":"Ratti S et al (2020) B-ALL complexity: is targeted therapy still a valuable approach for pediatric patients? Cancers (Basel) 12(12):3498","DOI":"10.3390\/cancers12123498"},{"issue":"1","key":"6957_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41375-022-01737-4","volume":"37","author":"K Ohki","year":"2023","unstructured":"Ohki K et al (2023) Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. Leukemia 37(1):212\u2013216","journal-title":"Leukemia"},{"issue":"8","key":"6957_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.6004\/jnccn.2024.0051","volume":"22","author":"B Shah","year":"2024","unstructured":"Shah B et al (2024) Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 22(8):563\u2013576","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"6957_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3324\/haematol.2017.186320","volume":"104","author":"K Ohki","year":"2019","unstructured":"Ohki K et al (2019) Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion. Haematologica 104(1):128\u2013137","journal-title":"Haematologica"},{"issue":"10","key":"6957_CR13","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1007\/s00277-024-05868-9","volume":"103","author":"HY Cao","year":"2024","unstructured":"Cao HY et al (2024) Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements. Ann Hematol 103(10):4155\u20134161","journal-title":"Ann Hematol"},{"issue":"12","key":"6957_CR14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1182\/blood.2022016241","volume":"140","author":"M Zhang","year":"2022","unstructured":"Zhang M et al (2022) Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion. Blood 140(12):1390\u20131407","journal-title":"Blood"},{"issue":"23","key":"6957_CR15","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","volume":"124","author":"J Irving","year":"2014","unstructured":"Irving J et al (2014) Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 124(23):3420\u20133430","journal-title":"Blood"},{"issue":"1","key":"6957_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-025-02310-y","volume":"10","author":"Q Xue","year":"2025","unstructured":"Xue Q et al (2025) Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL. Signal Transduct Target Ther 10(1):230","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"6957_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","volume":"15","author":"J Li","year":"2021","unstructured":"Li J et al (2021) Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia. Front Med 15(3):347\u2013371","journal-title":"Front Med"},{"issue":"21","key":"6957_CR18","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","volume":"63","author":"TCS Ho","year":"2020","unstructured":"Ho TCS, Chan AHY, Ganesan A (2020) Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. J Med Chem 63(21):12460\u201312484","journal-title":"J Med Chem"},{"key":"6957_CR19","doi-asserted-by":"publisher","first-page":"110330","DOI":"10.1016\/j.biopha.2020.110330","volume":"128","author":"N Tange","year":"2020","unstructured":"Tange N et al (2020) Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells. Biomed Pharmacother 128:110330","journal-title":"Biomed Pharmacother"},{"key":"6957_CR20","doi-asserted-by":"publisher","first-page":"212574","DOI":"10.7573\/dic.212574","volume":"8","author":"LM Juarez-Salcedo","year":"2019","unstructured":"Juarez-Salcedo LM, Desai V, Dalia S (2019) Venetoclax: evidence to date and clinical potential. Drugs Context 8:212574","journal-title":"Drugs Context"},{"issue":"1","key":"6957_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/hematology.2023000422","volume":"2023","author":"R Epperly","year":"2023","unstructured":"Epperly R, Shah NN (2023) Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL. Hematol Am Soc Hematol Educ Program 2023(1):77\u201383","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"6957_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bjh.20134","volume":"207","author":"AC Wilke","year":"2025","unstructured":"Wilke AC, Gokbuget N (2025) The role of blinatumomab in adult acute B lymphoblastic leukaemia. Br J Haematol 207(1):27\u201342","journal-title":"Br J Haematol"},{"issue":"1","key":"6957_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00277-019-03857-x","volume":"99","author":"J Sun","year":"2020","unstructured":"Sun J, Yu W, Zhang X (2020) MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma\/leukemia. Ann Hematol 99(1):185\u2013188","journal-title":"Ann Hematol"},{"issue":"1","key":"6957_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41467-022-29224-5","volume":"13","author":"IR Leo","year":"2022","unstructured":"Leo IR et al (2022) Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. Nat Commun 13(1):1691","journal-title":"Nat Commun"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06957-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06957-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:24Z","timestamp":1776405564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06957-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6957"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06957-7","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Research Ethical Review Committee of the First Affiliated Hospital of Soochow University, following institutional guidelines and in accordance with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"200"}}